On Tuesday, Werewolf Therapeutics Inc (NASDAQ: HOWL) opened lower -8.11% from the last session, before settling in for the closing price of $2.96. Price fluctuations for HOWL have ranged from $1.66 to $8.19 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 5.40% over the last five years. Company’s average yearly earnings per share was noted -53.81% at the time writing. With a float of $30.40 million, this company’s outstanding shares have now reached $39.11 million.
The firm has a total of 47 workers. Let’s measure their productivity. In terms of profitability, gross margin is 80.36%, operating margin of -628.41%, and the pretax margin is -578.8%.
Werewolf Therapeutics Inc (HOWL) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Werewolf Therapeutics Inc is 30.45%, while institutional ownership is 58.46%.
Werewolf Therapeutics Inc (HOWL) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -53.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.90% during the next five years compared to -13.31% drop over the previous five years of trading.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Trading Performance Indicators
Check out the current performance indicators for Werewolf Therapeutics Inc (HOWL). In the past quarter, the stock posted a quick ratio of 12.13. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.35, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.92 in one year’s time.
Technical Analysis of Werewolf Therapeutics Inc (HOWL)
Analysing the last 5-days average volume posted by the [Werewolf Therapeutics Inc, HOWL], we can find that recorded value of 1.71 million was better than the volume posted last year of 0.36 million. As of the previous 9 days, the stock’s Stochastic %D was 42.52%. Additionally, its Average True Range was 0.34.
During the past 100 days, Werewolf Therapeutics Inc’s (HOWL) raw stochastic average was set at 42.06%, which indicates a significant increase from 38.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 184.80% in the past 14 days, which was higher than the 114.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.25, while its 200-day Moving Average is $4.04. Now, the first resistance to watch is $2.89. This is followed by the second major resistance level at $3.06. The third major resistance level sits at $3.16. If the price goes on to break the first support level at $2.62, it is likely to go to the next support level at $2.52. Should the price break the second support level, the third support level stands at $2.35.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Key Stats
There are currently 43,702K shares outstanding in the company with a market cap of 118.86 million. Presently, the company’s annual sales total 19,940 K according to its annual income of -37,370 K. Last quarter, the company’s sales amounted to 1,140 K and its income totaled -17,250 K.
